ESC Premium Access

Second-generation drug-eluting stents versus coronary artery bypass surgery in patients with stable angina and an isolated lesion in the proximal left anterior descending artery

Congress Session

About the speaker

Professor Konstantinos Toutouzas

University of Athens, Athens (Greece)
2 presentations
0 follower

26 more presentations in this session

Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free biolimus A9-coated stent: insights from the all-comers FREEDOM registry

Speaker: Doctor G. Gallone (Turin, IT)

Thumbnail

Long term clinical outcome of a novel sirolimus-eluting coronary stent in patients with acute myocardial infarction

Speaker: Doctor S. Dani (Ahmedabad, IN)

Thumbnail

Biodegradable polymer everolimus-eluting stents versus durable polymer everolimus-eluting stents in diabetic patients : a 3-year propensity-matched study

Speaker: Doctor H. Matsuda (Nagoya, JP)

Thumbnail

Clinical outcomes of an ultra-thin strut sirolimus-eluting stent with biodegradable polymer in all-comers patients undergoing coronary intervention

Speaker: Doctor I. Menown (Craigavon, GB)

Thumbnail

Final 5-year outcomes of the TRIAS High Risk of Restenosis; a multi-centre, randomized trial comparing endothelial progenitor cell capturing stent with drug-eluting stents

Speaker: Miss L. Kerkmeijer (Zwolle, NL)

Thumbnail

Access the full session

Poster Session 3 - Percutaneous coronary syndrome: pharma and devices

Speakers: Professor K. Toutouzas, Doctor G. Gallone, Doctor S. Dani, Doctor H. Matsuda, Doctor I. Menown...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk